Investment Adventures in Emerging Markets


Emerging Markets Insights: Optimism on 2023 outlook

As we head further into 2023, our Franklin Templeton Emerging Markets Equity Team finds many reasons to be constructive about emerging markets.

Three things we’re thinking about today

We are optimistic that emerging markets, in particular Chinese equities, can post positive returns in 2023. Drivers of our optimism include:

1͏. China dismantles its zero-COVID policies: The removal of almost all COVID-19 restrictions in China is resulting in a wave of infections, with up to 80% of people in urban areas contracting the virus. As the wave subsides, economic activity is expected to normalize. Durable goods and financial services are likely beneficiaries of a resumption in normal patterns of human interaction and trade. A recovery in outward-bound tourism is expected to benefit economies in Asia, which prior to 2020 were the prime beneficiaries of the large number of Chinese tourists.

2. Peak in US interest rates: Consensus expectations1 point to two further increases in the US federal funds rate in 2023. While the timing of eventual rate cuts remains uncertain, the peak in rate hikes is the first step on this journey. The US dollar has already reacted to expectations of a peak in interest rates in 2023, trending lower in recent months. US dollar weakness should benefit emerging market fund flows, reversing the outflows of recent years, which in turn is supportive of emerging market equities.

3. Acceleration in renewable energy investments: The “new normal” of elevated fossil fuel prices is likely to incentivize emerging markets to accelerate decarbonization efforts in order to reduce energy costs and meet their Paris Climate accord targets. This will create potential opportunities for emerging market investors. The battery industry—for both electric vehicles and battery electric storage systems—as well as the solar industry, stand out. China and South Korea are at the forefront of new battery technologies, commanding 83% global market share between January-October 2022.2 India is also investing heavily in the solar industry as it seeks to become self-sufficient in photovoltaic panel production.


As we head further into 2023, we find many reasons to be constructive about emerging markets (EMs). Markets such as Chile and Indonesia have started to pause interest-rate hikes or scale back the magnitude of their rate hikes. We expect a policy pivot to revive consumption and spur economic growth as inflation slows. In addition, after a slowdown in earnings in 2022, there is a prospect for a recovery in earnings growth in 2023. We view China as a leader with a near-15% estimated growth, based on consensus expectations.3 However, we are of the view that earnings may continue to still be relatively weaker in China in the near term, with a recovery timed toward the end of 2023 instead. Nonetheless, a pickup in earnings revisions in EMs would signify better times ahead for earnings and in turn, equities.

Although a weakening global outlook appears to be on the horizon, economies with a greater focus on domestic demand are better placed to weather a challenging environment. These markets include EM countries such as India, Brazil and Indonesia.

India has attracted investors looking to diversify their manufacturing bases from China. Similarly, the Middle East is experiencing an upturn in consumption, due to a spillover from high energy prices.

China’s recent policy changes and low equity valuations have created opportunities locally as well as in Asia more broadly, as China is the largest driver of economic activity in the region. China’s reopening could benefit EMs outside of Asia as well. As mobility in China bounces back to pre-pandemic levels, its demand for oil will also likely increase. This benefits several non-Asian EMs which supply crude oil to China, including Saudi Arabia, Kuwait and Colombia. While the risks of 2022 have abated slightly, we remain watchful for developments that could change our overall EM outlook, including China’s relationship with Taiwan and the United States.

As the investment environment evolves, an important feature that we seek in EMs is resilience, in terms of both economies and companies. A particular area of focus for us is the sustainability of corporate earnings, whether in the face of COVID-19, policy changes, technology disruption or other challenges. We see companies with structural growth drivers aligned with digitalization, decarbonization and premiumization emerging as long-term winners.


All investments involve risks, including possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested. Stock prices fluctuate, sometimes rapidly and dramatically, due to factors affecting individual companies, particular industries or sectors, or general market conditions. Special risks are associated with investing in foreign securities, including risks associated with political and economic developments, trading practices, availability of information, limited markets and currency exchange rate fluctuations and policies; investments in emerging markets involve heightened risks related to the same factors. Investments in fast-growing industries like the technology and health care sectors (which have historically been volatile) could result in increased price fluctuation, especially over the short term, due to the rapid pace of product change and development and changes in government regulation of companies emphasizing scientific or technological advancement or regulatory approval for new drugs and medical instruments. China may be subject to considerable degrees of economic, political and social instability. Investments in securities of Chinese issuers involve risks that are specific to China, including certain legal, regulatory, political and economic risks.

Important Legal Information

This material is intended to be of general interest only and should not be construed as individual investment advice or a recommendation or solicitation to buy, sell or hold any security or to adopt any investment strategy. It does not constitute legal or tax advice. This material may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

The views expressed are those of the investment manager and the comments, opinions and analyses are rendered as at publication date and may change without notice. The underlying assumptions and these views are subject to change based on market and other conditions and may differ from other portfolio managers or of the firm as a whole. The information provided in this material is not intended as a complete analysis of every material fact regarding any country, region or market. There is no assurance that any prediction, projection or forecast on the economy, stock market, bond market or the economic trends of the markets will be realized. The value of investments and the income from them can go down as well as up and you may not get back the full amount that you invested. Past performance is not necessarily indicative nor a guarantee of future performance. All investments involve risks, including possible loss of principal.

Any research and analysis contained in this material has been procured by Franklin Templeton for its own purposes and may be acted upon in that connection and, as such, is provided to you incidentally. Data from third party sources may have been used in the preparation of this material and Franklin Templeton (“FT”) has not independently verified, validated or audited such data. Although information has been obtained from sources that Franklin Templeton believes to be reliable, no guarantee can be given as to its accuracy and such information may be incomplete or condensed and may be subject to change at any time without notice. The mention of any individual securities should neither constitute nor be construed as a recommendation to purchase, hold or sell any securities, and the information provided regarding such individual securities (if any) is not a sufficient basis upon which to make an investment decision. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments, opinions and analyses in the material is at the sole discretion of the user.

Products, services and information may not be available in all jurisdictions and are offered outside the U.S. by other FT affiliates and/or their distributors as local laws and regulation permits. Please consult your own financial professional or Franklin Templeton institutional contact for further information on availability of products and services in your jurisdiction.

Issued in the U.S. by Franklin Distributors, LLC, One Franklin Parkway, San Mateo, California 94403-1906, (800) DIAL BEN/342-5236, – Franklin Distributors, LLC, member FINRA/SIPC, is the principal distributor of Franklin Templeton U.S. registered products, which are not FDIC insured; may lose value; and are not bank guaranteed and are available only in jurisdictions where an offer or solicitation of such products is permitted under applicable laws and regulation.

1. Source: Bloomberg, January 5, 2023.

2. Source: SNE Research.

3. Source: Bloomberg, January 5, 2023.

Get Content Alerts in My Inbox

Receive email alerts when a new blog is posted.

Leave a reply

Your email address will not be published. Required fields are marked *